CoChat

Diagnostic Accuracy of Quantitative PCR (Xpert MTB/RIF) for Tuberculous Meningitis in a High Burden Setting: A Prospective Study

Open access

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Tuberculous meningitis (TBM) is difficult to diagnose promptly. The utility of the Xpert MTB/RIF test for the diagnosis of TBM remains unclear, and the effect of host- and sample-related factors on test performance is unknown. This study sought to evaluate the sensitivity and specificity of Xpert MTB/RIF for the diagnosis of TBM. METHODS AND FINDINGS: 235 South-African patients with a meningeal-like illness were categorised as having definite (culture or Amplicor PCR positive), probable (anti-TBM treatment initiated but microbiological confirmation lacking), or non-TBM. Xpert MTB/RIF accuracy was evaluated using 1 ml of uncentrifuged and, when available, 3 ml of centrifuged cerebrospinal fluid (CSF). To evaluate the incremental value of MTB/RIF over a clinically based diagnosis, test accuracy was compared to a clinical score (CS) derived using basic clinical and laboratory information. Of 204 evaluable patients (of whom 87% were HIV-infected), 59 had definite TBM, 64 probable TBM, and 81 non-TBM. Overall sensitivity and specificity (95% CI) were 62% (48%-75%) and 95% (87%-99%), respectively. The sensitivity of Xpert MTB/RIF was significantly better than that of smear microscopy (62% versus 12%; p = 0.001) and significantly better than that of the CS (62% versus 30%; p = 0.001; C statistic 85% [79%-92%]). Xpert MTB/RIF sensitivity was higher when centrifuged versus uncentrifuged samples were used (82% [62%-94%] versus 47% [31%-61%]; p = 0.004). The combination of CS and Xpert MTB/RIF (Xpert MTB/RIF performed if CS<8) performed as well as Xpert MTB/RIF alone but with a ∼10% reduction in test usage. This overall pattern of results remained unchanged when the definite and probable TBM groups were combined. Xpert MTB/RIF was not useful in identifying TBM among HIV-uninfected individuals, although the sample was small. There was no evidence of PCR inhibition, and the limit of detection was ∼80 colony forming units per millilitre. Study limitations included a predominantly HIV-infected cohort and the limited number of culture-positive CSF samples. CONCLUSIONS: Xpert MTB/RIF may be a good rule-in test for the diagnosis of TBM in HIV-infected individuals from a tuberculosis-endemic setting, particularly when a centrifuged CSF pellet is used. Further studies are required to confirm these findings in different settings. Please see later in the article for the Editors' Summary.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pmed.1001536

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Summary flow chart of patient recruitment and diagnostic testing performed. MGIT, Bactec MGIT 960; ND, not done; +ve, positive; −ve, negative. * These patients could not be clearly categorised as definite TBM, probable TBM, or non-TBM (e.g., reference negative and lost to follow-up, and without initiation of TB treatment). † Note that the uncentrifuged and centrifuged Xpert MTB/RIF groups include 12 patients who had both processes done, i.e., paired samples.
Figure 1 Summary flow chart of patient recruitment and diagnostic testing performed. MGIT, Bactec MGIT 960; ND, not done; +ve, positive; −ve, negative. * These patients could not be clearly categorised as definite TBM, probable TBM, or non-TBM (e.g., reference negative and lost to follow-up, and without initiation of TB treatment). † Note that the uncentrifuged and centrifuged Xpert MTB/RIF groups include 12 patients who had both processes done, i.e., paired samples.CC BY · PubMed Central
Figure 2 Level of detection of CSF Xpert MTB/RIF for M. tuberculosis using serial dilutions (500, 250, 100, 80, and 10 colony forming units per millilitre) of H37Rv. CFU, colony forming units.
Figure 2 Level of detection of CSF Xpert MTB/RIF for M. tuberculosis using serial dilutions (500, 250, 100, 80, and 10 colony forming units per millilitre) of H37Rv. CFU, colony forming units.CC BY · PubMed Central
Figure 3 Correlation of CSF Xpert MTB/RIF cycle threshold (C T) and Bactec MGIT 960 time to positive culture in all samples (both centrifuged and uncentrifuged).
Figure 3 Correlation of CSF Xpert MTB/RIF cycle threshold (C T) and Bactec MGIT 960 time to positive culture in all samples (both centrifuged and uncentrifuged).CC BY · PubMed Central
Figure 4 Comparison of PCR inhibition using the comparative internal positive control C T values in CSF and sputum (all HIV-infected patients). CSF IPC: median (IQR) C T value is 27.2 (range: 27.83–35.4), n = 82. Sputa IPC: median (IQR) C T value is 29.85 (range: 31.9–40.5), n = 238. Comparison between C T values for CSF and sputum, p≤0.001.
Figure 4 Comparison of PCR inhibition using the comparative internal positive control C T values in CSF and sputum (all HIV-infected patients). CSF IPC: median (IQR) C T value is 27.2 (range: 27.83–35.4), n = 82. Sputa IPC: median (IQR) C T value is 29.85 (range: 31.9–40.5), n = 238. Comparison between C T values for CSF and sputum, p≤0.001.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 39 references

Cited by

See all 179

Metadata

Authors
Patel, V. B., Theron, G., Lenders, L., Matinyena, B., Connolly, C., Singh, R., Coovadia, Y., Ndung'u, T., & Dheda, K.
Affiliations
  • University of KwaZulu-Natal (ZA)
  • University of Cape Town (ZA)
  • South African Medical Research Council (ZA)
  • National Health Laboratory Service (ZA)
Corresponding author
  • Patel, Vinod B.
  • Dheda, Keertan
Venue
PLoS Medicine
Published
2013-10-22
Volume
10
Issue
10
Pages
e1001536
ISSN
  • 1549-1277 (ISSN-L)
  • 1549-1676
OpenAlex
W2015704537
Cited by
179
References
39
Citations by year
2026: 3 · 2025: 6 · 2024: 5 · 2023: 7 · 2022: 10 · 2021: 11 · 2020: 17 · 2019: 23 · 2018: 23 · 2017: 19 · 2016: 14 · 2015: 17 · 2014: 23 · 2013: 1
FWCI
18.09
Type
journal article
Language
en
Open access
Locations
  • PLoS Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
  • Open University of Cape Town (University of Cape Town) (submittedVersion, cc-by)
Funders
  • Wellcome Trust (EU-FP7-)
  • National Research Foundation
  • Claude Leon Foundation
  • Inyuvesi Yakwazulu-Natali
  • Victor Daitz Foundation
  • National Institutes of Health
  • Medical Research Council (EU FP7)
  • Fogarty International Center (D43-TW00231, D43TW000231)
  • European and Developing Countries Clinical Trials Partnership
Topics
  • Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
  • Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
  • Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
Keywords
tuberculous meningitis, Xpert MTB/RIF, real-time PCR, diagnostic accuracy, sensitivity and specificity, cerebrospinal fluid, centrifugation, smear microscopy, clinical scoring systems, HIV infection, PCR inhibition, South Africa, rapid molecular diagnostics, cost-effectiveness of testing, smear-negative tuberculosis, smear-positive tuberculosis
MeSH terms
Adult, Female, Humans, Male, Prospective Studies, Tuberculosis, Meningeal, Polymerase Chain Reaction, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Diagnostic Accuracy of Quantitative PCR (Xpert MTB/RIF) for Tuberculous Meningitis in a High Burden Setting: A Prospective Study. https://app.cochat.ai/papers/10.1371/journal.pmed.1001536
The paper
Patel, V. B., Theron, G., Lenders, L., Matinyena, B., Connolly, C., Singh, R., Coovadia, Y., Ndung'u, T., & Dheda, K. (2013). Diagnostic Accuracy of Quantitative PCR (Xpert MTB/RIF) for Tuberculous Meningitis in a High Burden Setting: A Prospective Study. PLoS Medicine. https://doi.org/10.1371/journal.pmed.1001536

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.